Author:
El-Shamy Ahmed,Pendleton Matthew,Eng Francis J.,Doyle Erin H.,Bashir Ali,Branch Andrea D.
Publisher
Springer Science and Business Media LLC
Reference32 articles.
1. El-Serag, H. B. Hepatocellular carcinoma. The New England journal of medicine 365, 1118–1127, 10.1056/NEJMra1001683 (2011).
2. Hoshida, Y., Fuchs, B. C. & Tanabe, K. K. Prevention of hepatocellular carcinoma: potential targets, experimental models, and clinical challenges. Current cancer drug targets 12, 1129–1159 (2012).
3. Aleman, S. et al. A risk for hepatocellular carcinoma persists long-term after sustained virologic response in patients with hepatitis C-associated liver cirrhosis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 57, 230–236, 10.1093/cid/cit234 (2013).
4. Davila, J. A. et al. Use of surveillance for hepatocellular carcinoma among patients with cirrhosis in the United States. Hepatology 52, 132–141, 10.1002/hep.23615 (2010).
5. Davila, J. A. et al. Utilization of surveillance for hepatocellular carcinoma among hepatitis C virus-infected veterans in the United States. Annals of internal medicine 154, 85–93 (2011).
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献